Celia D. Examining the FDA’s Drug Approvals Process. First Report. Celia examines the complexities of the FDA’s drug approval process. In this article, the author examines the approval process using the new drug, Aducanumab, as an example. The author meticulously inspects the FDA’s drug approval process from healthcare and legislative perspectives. Additionally, in theRead more
Harber ML. Pharmacy Trends, Litigation, and Legislation. HRProfessionalsMagazine. https://hrprofessionalsmagazine.com/2020/07/31/pharmacy-trends-litigation-and-legislation/. Published August 3, 2020. Employer-sponsored health and pharmacy plans continue to experience rising costs in their drug expenditures. During these times of economic slowdown, financial uncertainty, and a greater focus on expense control, employers have an opportunity to look at different ways to manage drugRead more
Larson C, Vogenberg FR. Guiding Employer Management of Specialty Drugs. Am Health Drug Benefits. 2015;8(5):256-257. With the 2015 extension of time offered to employers for Affordable Care Act (ACA) compliance, many employers are back to focusing their attention on cost management efforts. For the fourth straight year, managing specialty pharmacy has been noted as oneRead more
O’Donnell JT, Vogenberg FR. The Opioid Crisis and What Has Been Learned. P T. 2019;44(12). So much to write, so little space. A real challenge for healthcare professionals (HCPs) and responsible healthcare organization operating committees like P&T is walking back care delivery and pharmaceutical prescribing practices that have existed for more than a century.Read more
Rumore MM, Vogenberg FR. PBM P&T Practices: The HEAT Initiative Is Gaining Momentum. P T. 2017;42(5):330-335. The origins of the modern P&T committee lie in hospital-based drug management practices. As managed care evolved and pharmacy benefit management (PBM) emerged through Medicaid and commercial insurance growth, many former hospital pharmacists moved into the growing variety ofRead more
